SPYRE THERAPEUTICS INC

Ticker: SYRE CUSIP: 00773J202 Class: Common Stock

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 275,065 Value ($000) $9,011 Avg Close $26.13 Range $15.86 - $35.31
Q3 2025
Shares 329,533 Value ($000) $5,523 Avg Close $16.31 Range $14.00 - $18.30
Q2 2025
Shares 523,416 Value ($000) $7,836 Avg Close $14.80 Range $10.91 - $19.20
Q1 2025
Shares 197,068 Value ($000) $3,180 Avg Close $20.81 Range $16.13 - $26.01
Q4 2024
Shares 747,552 Value ($000) $17,403 Avg Close $29.32 Range $22.37 - $40.26
Q3 2024
Shares 169,314 Value ($000) $4,980 Avg Close $27.85 Range $23.00 - $32.41
Q2 2024
Shares 893,083 Value ($000) $20,996 Avg Close $33.73 Range $22.19 - $40.84
Q1 2024
Shares 239,915 Value ($000) $9,100 Avg Close $28.97 Range $18.54 - $47.97